Besides, increase in the activity of NF-κB can induce the drug tolerance of esophageal tumor cells,9 so inhibiting its activity is able to enhance the radiosensitivity.10 In contrast, activation of NF-κB is bound to reduce the radiosensitivity of esophageal tumor cells. Here, NFKB1 is linked to neoplasm of esophagus.